唑来膦酸治疗老年女性骨质疏松性骨折的研究
Efficacy of zoledronic acid in the treatment of elderly women with osteoporotic fractures
  
DOI:10.3969/j.issn.1006-7108.2014.10.021
中文关键词:  唑来膦酸  骨质疏松性骨折  骨密度  疗效
英文关键词:Zoledronic acid  Osteoporotic fracture  Bone mineral density  Efficacy
基金项目:
作者单位
李祖涛 孙俊刚 徐万龙 缪晓刚 徐江波 袁宏* 新疆自治区人民医院骨一科,乌鲁木齐830001 
摘要点击次数: 3051
全文下载次数: 2069
中文摘要:
      目的 研究唑来膦酸治疗老年女性骨质疏松性骨折的疗效。方法 选择2009年至2010年住院的60岁以上女性长骨骨折患者192例检测BMD,分为治疗组和对照组,两组均在治疗骨折同时给予钙剂和骨化三醇治疗,治疗组于术后1-2周给予唑来膦酸5mg静脉滴注。术后每12个月复查并记录腰椎部骨密度变化,同时观察术后骨折愈合情况、3年内再骨折率的差异。结果 在治疗三年后治疗组骨密度较对照组均有所提高,且差异有统计学意义(p<0.05);术后三年内治疗组再骨折率低于对照组,且差异有统计学意义(p<0.05);在骨折愈合方面两组随访3月骨折均愈合良好,结果差异无统计学意义(p>0.05)。结论 唑来膦酸可以有效降低老年女性骨质疏松性骨折患者的再骨折率、提高骨密度,且并不影响骨折愈合。
英文摘要:
      Objective To study the curative effect of zoledronic acid on osteoporotic fractures in elder women. Methods A total of 192 patients, aging over 60 years, with osteoporotic fractures were enrolled and assigned into 2 groups from 2009 to 2010. Patients in both groups received Caltrate D and Calcitriol while receiving fracture treatment. Patients in the treatment group received 5 mg zoledronic acid infusion 1-2 weeks after the operation. Bone mineral density (BMD) of the lumbar spine was measured using dual-energy X-ray absorptiometry (DXA) every 12 months after the operation. Fracture healing and the rate of second fractures in 3 years were also observed. Results The BMD in treatment group was significantly higher than in control group (P<0.05) in the 3-year treatment period. The rate of second fractures in treatment group was obviously lower than in control group, with statistical significance (P<0.05). And the fractures healed well in both groups within 3-month follow-up. Conclusion Zoledronic acid can significantly reduce the rate of second fractures, improve BMD in elderly women, with no influence in the fracture healing.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=d842c0986c5170157c3d75afe660e6b8a0c403420e3e0b2fcbd16bbca9111ef77d888aea39c196470cf6b0ad1610040125310d14a9ea6bd838c7d236b3b769080768ad3d233408053cbccd43735db1dd569470dab0c99a3ed2b45ab2cae66037&pcid=3b2e4763797f121df1e5c0ba55cffa7b&cid=b38b646414cdcf7db2ea2d31acb25be6&jid=eee368637b75dadee990b657cb57bb74&yid=1898ad1ee165de0161ce7bd1b9e573e4&aid=cdd730241605500a985d91e6b7883a9ed055c0e69d9f8e5a06e10b44da64cf64&vid=&iid=061b1aa4c70fe659d4fb2236af2f304e&sid=307d5fe7fd7aff6c0b56eef39fdf28a9&eid=9e052b8769abf7c1cc7bf97f38a35837&fileno=20141021&flag=1&is_more=0"> var my_pcid="3b2e4763797f121df1e5c0ba55cffa7b"; var my_cid="b38b646414cdcf7db2ea2d31acb25be6"; var my_jid="eee368637b75dadee990b657cb57bb74"; var my_yid="1898ad1ee165de0161ce7bd1b9e573e4"; var my_aid="cdd730241605500a985d91e6b7883a9ed055c0e69d9f8e5a06e10b44da64cf64";